Head to head
Otter Tail vs 3M
Side-by-side on the measures that matter, with a plain-English read. Full detail: OTTR · MMM
OTTR
Otter Tail
76.58-2.12%
1-year price shape — -8% over the period
Quant Rating D · 34/100
vs
MMM
3M
177.99-0.27%
1-year price shape — +10% over the period
Quant Rating C · 51/100
1-year performance, rebased to 100
3M edges it on the scoreable measures. 3M has the highest Quant Rating (51); 3M has done best over the past year (+10%).
| OTTR | MMM | |
|---|---|---|
| Snapshot | ||
| Sector | Conglomerates | -- |
| Last price | 76.58 | 177.99 |
| Change today | -2.12% | -0.27% |
| 1-year return | -8.3% | +9.7% |
| Market cap | $3.22B | $91.97B |
| 52-week range | 74.00 – 93.77 | 137.44 – 196.08 |
| Valuation | ||
| P/E (TTM) | 18.32 | 26.57 |
| P/E percentile, own 5-yr range | 91st | 83rd |
| P/B | 1.68 | 22.28 |
| Dividend yield | 2.95% | 1.72% |
| Profitability & growth | ||
| EPS (TTM) | 6.55 | 6.00 |
| Net profit (TTM) | $275.01M | $3.10B |
| Revenue (TTM) | $1.31B | $25.25B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | -1.6% | +1.0% |
| Gross margin | 40.5% | 39.5% |
| Operating margin | 23.0% | 20.1% |
| Net margin | 13.5% | 14.0% |
| Free cash flow (TTM) | $-121.39M | $2.68B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 77.4% | 77.0% |
| Insider activity (12mo) | 32 buy / 15 sell | 24 buy / 22 sell |
| Short interest (% of float) | 11.1% | 1.9% |
| Analyst consensus | 100% hold (3) | 36% buy / 55% hold / 9% sell (11) |
| Analyst price target | $85 (+11%) | $198 (+11%) |
| StockVane view | ||
| StockVane Quant Rating | D (34) | C (51) |
| Company | ||
| Employees | 2,198 | 60,500 |
| Founded | 1907 | 1929 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.